| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/09/2013 | US20130115276 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115275 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115267 Compositions and methods for reducing edema |
| 05/09/2013 | US20130115257 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/09/2013 | US20130115247 Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy |
| 05/09/2013 | US20130115239 Prostate cancer dna vaccine |
| 05/09/2013 | US20130115233 Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
| 05/09/2013 | US20130115228 Immunostimulatory combinations |
| 05/09/2013 | US20130115226 Methods and uses of tie2 binding and/or activating agents |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/09/2013 | US20130115216 Survivin-derived peptides and uses thereof |
| 05/09/2013 | US20130115211 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 05/09/2013 | US20130115210 Peptide for Use in the Treatment of Breast Cancer and/or Bone Metastases |
| 05/09/2013 | US20130115203 Enzyme and Prebiotic Combinations for Enhancing Probiotic Efficacy |
| 05/09/2013 | US20130115196 Hybrid hydrogel scaffold compositions and methods of use |
| 05/09/2013 | US20130115195 Anti-Aging Formulations |
| 05/09/2013 | US20130115194 Hepatitis c virus inhibitors |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/09/2013 | US20130115190 Hepatitis C Virus Inhibitors |
| 05/09/2013 | US20130115170 Gm1-like peptides and uses thereof |
| 05/09/2013 | US20130115133 Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums |
| 05/08/2013 | EP2589658A1 Partial region polypeptide of reic/dkk-3 protein |
| 05/08/2013 | EP2589605A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2589390A1 Pharmaceutical composition for treating central and peripheral nervous system diseases of vascular, traumatic, toxic, hypoxic and autoimmune origin |
| 05/08/2013 | EP2588491A2 Novel peptide and use thereof |
| 05/08/2013 | EP2588490A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/08/2013 | EP2588489A2 Biomimetic peptides for bone augmentation |
| 05/08/2013 | EP2588132A2 Methods and compositions for cns delivery of -galactocerebrosidase |
| 05/08/2013 | EP2588131A2 Methods and compositions for cns delivery of heparan n-sulfatase |
| 05/08/2013 | EP2588130A1 Cns delivery of therapeutic agents |
| 05/08/2013 | EP2588129A2 Small-molecule-targeted protein degradation |
| 05/08/2013 | EP2588128A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 05/08/2013 | EP2588127A1 Dipeptide linked medicinal agents |
| 05/08/2013 | EP2588126A2 Amide based glucagon superfamily peptide prodrugs |
| 05/08/2013 | EP2588125A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 05/08/2013 | EP2588124A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 05/08/2013 | EP2588123A2 C1orf32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders |
| 05/08/2013 | EP2588122A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 05/08/2013 | EP2588121A2 Analogs of c5a and methods of using same |
| 05/08/2013 | EP2588120A2 Compositions and methods related to protein a (spa) variants |
| 05/08/2013 | EP2588074A1 Sirtuin-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
| 05/08/2013 | EP2502939A9 Nonnatural collagen-like protein and use thereof |
| 05/08/2013 | DE102011117839A1 Herstellung von Hydrogelen mittels Diels-Alder Reaktion Preparation of hydrogels by Diels-Alder reaction |
| 05/08/2013 | CN1954217B A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an HIV virus in an individual |
| 05/08/2013 | CN103097535A Method for producing novel hipsc by means of sirna introduction |
| 05/08/2013 | CN103097524A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| 05/08/2013 | CN103097523A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl tRNA synthetases |
| 05/08/2013 | CN103097522A Method of producing recombinant ADAMTS13 in cell culture |
| 05/08/2013 | CN103097409A Method of producing recombinant high molecular weight vWF in cell culture |
| 05/08/2013 | CN103097405A Novel peptides for wound healing |
| 05/08/2013 | CN103097403A Chlorotoxin variants, conjugates, and methods for their use |
| 05/08/2013 | CN103097402A Contraceptive peptides derived from spider venom |
| 05/08/2013 | CN103097399A Compositions and methods for the removal of biofilms |
| 05/08/2013 | CN103097398A Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
| 05/08/2013 | CN103096944A Sheet preparation for tissue adhesion |
| 05/08/2013 | CN103096925A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases |
| 05/08/2013 | CN103096918A CNS delivery of therapeutic agents |
| 05/08/2013 | CN103096917A Trefoil factors (TFF) for the treatment of chronic pulmonary diseases |
| 05/08/2013 | CN103096916A Formulations for bovine granulocyte colony stimulating factor and variants thereof |
| 05/08/2013 | CN103096915A Immunosuppression modulating compounds |
| 05/08/2013 | CN103096914A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| 05/08/2013 | CN103096913A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
| 05/08/2013 | CN103096912A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| 05/08/2013 | CN103096911A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 05/08/2013 | CN103096910A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
| 05/08/2013 | CN103096909A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases |
| 05/08/2013 | CN103087200A Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein |
| 05/08/2013 | CN103087199A Gastric cancer targeted recombinant toxin and preparation method thereof |
| 05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
| 05/08/2013 | CN103087180A Glucagon-like peptide 1 (GLP-1) analogues with long-acting effect and application thereof |
| 05/08/2013 | CN103087179A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087178A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087177A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087176A Long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087175A Novel long-acting glucagon-like peptide 1 (GLP-1) analogues and application thereof |
| 05/08/2013 | CN103087174A GLP-1 derivative DLG3312 and solid-phase chemical synthesis method thereof |
| 05/08/2013 | CN103087172A Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/08/2013 | CN103087170A Macrophage migration inhibition factor and preparation and application thereof |
| 05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
| 05/08/2013 | CN103087151A Novel polypeptide used for treating tissue inflammation |
| 05/08/2013 | CN103083681A Drug for treating tumors and application thereof |
| 05/08/2013 | CN103083678A Method for modifying uricase by active polyethylene glycol (PEG) against amino group under protection of competitive inhibitor |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083651A Cell-penetrating peptide-mediated botulinum toxin composition for external preparation as well as preparation method and application of botulinum toxin composition |
| 05/08/2013 | CN103083650A Composition with bone mineral density addition function, and preparation method as well as application of composition |
| 05/08/2013 | CN103083649A Chewing gum for preventing and treating oral ulcer resulted from chemotherapy |
| 05/08/2013 | CN103083648A Troche for enhancing bone mineral density based on milk mineral salt as raw material as well as preparation method thereof |
| 05/08/2013 | CN103083647A Application of recombinant human cell globin in preparation of fatty liver medicament |
| 05/08/2013 | CN103083646A Application of poly cytosine binding protein-1 in preparation of medicine for preventing and treating Parkinson disease |
| 05/08/2013 | CN103083645A Application of neuregulin 1 and acceptor thereof as target for preparing and screening anti-epileptic drugs |
| 05/08/2013 | CN103083644A Dimeric iap inhibitors |
| 05/08/2013 | CN103083643A Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates |
| 05/08/2013 | CN103083642A Aloe preparation for skin enhancement |
| 05/08/2013 | CN103083621A Medical composition for treating osteoarthritis |
| 05/08/2013 | CN103083590A Medicine used for treating decompensated liver cirrhosis, and preparation method thereof |
| 05/08/2013 | CN103083226A Preparation of gel containing fibroblast growth factor-1 modified body and application thereof for treating diabetic foot |
| 05/08/2013 | CN103082276A Composition for reducing sport injury and promoting sport injury repair |
| 05/08/2013 | CN102475890B Acceptor protein, and coding gene and application thereof |